tobramycin
General
Genetic Implications:
Pronunciation:
toe-bra-mye-sin
![](.//images/locked-audio.png)
Trade Name(s)
- Bethkis
- Kitabis Pak
- TOBI
- TOBI Podhaler
Ther. Class.
anti-infectives
Pharm. Class.
aminoglycosides
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Tobramycin." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109093/10.0/tobramycin.
Vallerand AHA, Sanoski CAC, Quiring CC. Tobramycin. Davis's Drug Guide. F.A. Davis Company; 2023. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109093/10.0/tobramycin. Accessed September 7, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Tobramycin. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109093/10.0/tobramycin
Vallerand AHA, Sanoski CAC, Quiring CC. Tobramycin [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 September 07]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109093/10.0/tobramycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - tobramycin
ID - 109093
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109093/10.0/tobramycin
PB - F.A. Davis Company
ET - 18
DB - Medicine Central
DP - Unbound Medicine
ER -